Literature DB >> 60289

Serologically detectable specific and cross-reactive antigens on the membrane of a polyoma virus-induced murine tumor.

I P Witz, N Lee, G Klein.   

Abstract

With the aid of an assay measuring complement-dependent cytotoxocity mediated by syngeneic antibodies, we performed a serological analysis of surface antigens of a polyoma-virus-induced murine tumor (SEYF-a). In vivo propagated SEYF-a ascites tumor cells expressed a specific membrane antigen in addition to various other cross-reacting antigens. Among these we could identify at least four separate specificities. Two of these were present on MuLV-induced lymphoma cells, the first on Moloney-virus-induced YAC cells and the second on Gross-virus-induced GHA cells. The third cross-reacting antigen was detected on EL-4 cells. At least one additional specificity was present on two methylcholantthrene-induced murine sarcomas. Normal syngeneic lymphoid cells were insensitive to cytotoxicity mediated by the anti-tumor antisera. Quantitative and perhaps also qualitative differences between that antigenic expression of in vivo propagated on cultured SEYF-a cells were indicated. These studies show that hyperimmune sera produced in syngeneic mice against transplanted tumors may contain a considerable number of antibody specificities, only some of which are specific for the tumor. Furthermore, the results also suggest that polyoma-virus-induced tumors may possess individually distinct antigenic specificities, over and above the known cross-reacting TSTA or TSSA type antigen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60289     DOI: 10.1002/ijc.2910180215

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

Review 1.  Membrane antigens associated with infection, transformation, and tumorigenesis by polyoma virus.

Authors:  I P Witz; G Meyer
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 2.  Immunopathology of polyoma-induced tumors.

Authors:  M Vandeputte
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Reduced humoral and cellular cytotoxic sensitivity in histocompatibility variants of the YAC (Moloney) lymphoma.

Authors:  T Dalianis; L Ahrlund-Richter; F Merino; E Klein; G Klein
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

Review 4.  FcR may function as a progression factor of nonlymphoid tumors.

Authors:  I P Witz; M Ran
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

5.  B16 melanoma development, NK activity cytostasis and natural antibodies in 3 and 12 month old mice.

Authors:  R Ehrlich; N Smorodinsky; M Efrati; M Yaakubowicz; I P Witz
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.